Most Recent
The companies behind the top selling Abilify medication have lost their latest bid for documents from the Commonwealth in a multimillion dollar dispute over the delayed listing of generic versions of their drug, with a judge saying the material could be only "of the most marginal relevance".
Petrol station operator Ampol has denied accusations by US oil giant Chevron that it is misusing Caltex branding on 175 of its service stations, on the first day of a trial that could see the presiding judge take a road trip to view the alleged offending signage firsthand.
The High Court will decide whether the Full Court was wrong to overturn a $26.3 million judgment for Danish drug maker H Lundbeck in its long-running patent battle with generic drug maker Sandoz over the patent for blockbuster antidepressant Lexapro.
Monster Energy, which makes Mother brand energy drinks, has appealed a ruling from IP Australia that granted rival caffeinated beverage maker Vittoria Food & Beverage's application for the removal of Monster's 'Motherland' trade mark for non-use.
Botox maker Allergan has appealed a court judgment tossing most of trade mark case against an Australian cosmetics company that sells topical creams as Botox alternatives.
A trade mark dispute between US oil giant Chevron and Australian petrol station operator Ampol has been set down for an expedited hearing in April, ahead of which the companies have been ordered into mediation.
A judge has told a unit of US energy giant Chevron Corporation to consider narrowing its trade mark dispute against Australian petrol station operator Ampol, as the parties consider whether to take the matter to an expedited hearing.
The maker of Mother energy drinks has had its Motherland trade mark removed by IP Australia, with a delegate granting a win to rival caffeinated beverage maker Vittoria Food & Beverage in finding that the mark should be removed for non-use.
Botox maker Allergan has lost a lawsuit that accused an Australian cosmetics company that sells topical creams as an alternative to Botox injections of infringing its Botox trade mark.
Forty-four barristers have ascended to the senior counsel ranks in NSW and Victoria, including the barrister that represented Geoffrey Rush in his high-profile defamation victory and a member of the legal team that successfully defended Westpac against ASIC's infamous 'Wagyu beef and shiraz' case.